Daniel Farey-Jones
Nov 17, 2021

Cannes Lions confirms physical return in 2022

Back to the South of France, on 20-24 June.

Cannes Lions confirms physical return in 2022

The Cannes Lions International Festival of Creativity will be held as a real-life event in 2022, back in its longtime home on the French Riviera on 20-24 June.

Having been forced to cancel the 2020 edition and to run a virtual event this year, the festival chairman Philip Thomas said: “We can’t wait to reunite the industry and bring the community together once again.”

Thomas added that the festival would build on the digital access introduced during the pandemic, stating that “as the world shifts and changes we know our role as conveners needs to evolve”.

This will involve Lions Membership, which is the digital subscription introduced in March 2020 and has more than 10,000 members.

Jurors will conduct the “initial stages” of judging remotely and assemble in Cannes for the “final stages”, according to Susie Walker, vice-president, awards and insight.

The 2022 edition is also intended to be the most sustainable of the festival's nearly 70-year history

It will open for entries and registrations on January 20.

Source:
Campaign UK

Related Articles

Just Published

4 hours ago

APAC is a market of inspiration: OMD's George Manas

In a conversation with Campaign, OMD's worldwide CEO George Manas and APAC CEO Charlotte Lee discuss everything from managing agency operations to cookie deprecation to Gen AI, diversity and more.

4 hours ago

Google delays cookie deprecation again: APAC adtech ...

Google will now phase out cookies entirely in 2025 after being told the concerns around Privacy Sandbox still need to be addressed.

7 hours ago

Cheuk Chiang assumes CEO role at Bastion's ANZ ...

Chiang moves from his position as APAC CEO of Dentsu Creative.

14 hours ago

Having the balls to check: How a pregnancy test ...

An Ogilvy-backed campaign’s 40-second ad features a pair of gonads — Tano and Nato — who take a pregnancy test and find out they are negative for testicular cancer.